Vivanza Biosciences Valuation

Is 530057 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 530057 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 530057's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 530057's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 530057?

Key metric: As 530057 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 530057. This is calculated by dividing 530057's market cap by their current revenue.
What is 530057's PS Ratio?
PS Ratio	1x
Sales	₹164.18m
Market Cap	₹156.00m

530057 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	35.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 530057's PS Ratio compare to its peers?

The above table shows the PS ratio for 530057 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.9x
543309 Adeshwar Meditex	0.5x	n/a	₹340.0m
540468 KMS Medisurgi	3x	n/a	₹412.5m
530427 Choksi Imaging	3.7x	n/a	₹281.1m
533212 GKB Ophthalmics	0.5x	n/a	₹503.6m
530057 Vivanza Biosciences	1x	n/a	₹156.0m

Price-To-Sales vs Peers: 530057 is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (1.9x).

Price to Sales Ratio vs Industry

How does 530057's PS Ratio compare vs other companies in the Asian Medical Equipment Industry?

30 Companies	Price / Sales	Estimated Growth	Market Cap

30 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 530057 is good value based on its Price-To-Sales Ratio (1x) compared to the Asian Medical Equipment industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is 530057's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

530057 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 530057's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹557.2m

Trades in pharmaceutical products.

539938

₹61.29

33.1%

-27.8%

Dr Lalchandani Labs

₹81.2m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.73

4.1%

-46.5%

N G Industries

₹566.9m

Provides various healthcare services in India.

530897

₹168.05

0.2%

2.7%